In addition, PCE also decreased the expression of ARs and SRC-1, thereby decreasing the expression of PSA, one of the downstream target genes on the AR-DHT axis associated with BPH progression due to hyperproliferation of stromal and epithelial cells. The gene discussed is NCOA1; the disease is benign prostatic hyperplasia.